Jane Street Group, LLC Nuvation Bio Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 297,329 shares of NUVB stock, worth $695,749. This represents 0.0% of its overall portfolio holdings.

Number of Shares

297,329

Previous 113,653 161.61%

Holding current value

$695,749

Previous $413,000 110.17%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.58 - $3.69 $473,884 - $677,764	183,676 Added 161.61%	297,329 $868,000
Q1 2024 May 15, 2024	SELL	$1.46 - $3.97 $87,451 - $237,795	-59,898 Reduced 34.51%	113,653 $413,000
Q4 2023 Feb 14, 2024	BUY	$0.96 - $1.53 $156,995 - $250,211	163,537 Added 1633.08%	173,551 $262,000
Q3 2023 Nov 14, 2023	SELL	$1.26 - $2.1 $30,463 - $50,771	-24,177 Reduced 70.71%	10,014 $13,000
Q2 2023 Aug 14, 2023	SELL	$1.56 - $1.84 $345,430 - $407,431	-221,430 Reduced 86.62%	34,191 $61,000
Q1 2023 May 15, 2023	BUY	$1.6 - $2.48 $156,163 - $242,052	97,602 Added 61.77%	255,621 $424,000
Q4 2022 Feb 14, 2023	BUY	$1.68 - $2.5 $1,406 - $2,092	837 Added 0.53%	158,019 $303,000
Q3 2022 Nov 14, 2022	SELL	$0.29 - $4.04 $10,265 - $143,011	-35,399 Reduced 18.38%	157,182 $352,000
Q2 2022 Aug 16, 2022	BUY	$3.24 - $5.85 $545,029 - $984,081	168,219 Added 690.5%	192,581 $624,000
Q1 2022 May 17, 2022	BUY	$4.6 - $8.83 $14,121 - $27,108	3,070 Added 14.42%	24,362 $128,000
Q4 2021 Feb 15, 2022	BUY	$7.75 - $10.05 $4,975 - $6,452	642 Added 3.11%	21,292 $181,000
Q3 2021 Nov 16, 2021	BUY	$7.78 - $10.0 $59,727 - $76,770	7,677 Added 59.18%	20,650 $205,000
Q2 2021 Aug 16, 2021	SELL	$9.22 - $14.48 $35,635 - $55,965	-3,865 Reduced 22.95%	12,973 $121,000
Q1 2021 May 18, 2021	BUY	$9.0 - $14.57 $151,542 - $245,329	16,838 New	16,838 $176,000

Others Institutions Holding NUVB

# of Institutions

152

Shares Held

123M

Call Options Held

9.7K

Put Options Held

6.5K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $508M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Nuvation Bio Inc. Transaction History